Many innovations have been implemented in the cardiovascular care sector, but there are still further gains to be made.
efficient diagnostics for effective healthcare.
The need for fast diagnostics at the point of care is growing, for example for chronic diseases such as diabetes or haemophilia. In-vitro diagnostics (IVD) offer opportunities in the field of microbiology, immuno- and clinical chemistry as well as molecular diagnostics. Because we understand the biochemistry behind the analysis, we are able to design and build a suitable instrument around this. We have knowledge of relevant technological developments, such as miniaturization, connectivity and artificial intelligence for this purpose. In this way we support providers of IVD technology and disposables and develop certified IVD solutions that are robust and user- and patient-friendly.
“we bring IVD one step closer.”
We focus on personal healthcare close to the patient, at the point of care. We do this in various ways, for example with IVD for (continuous) testing at home, while on the road or at the healthcare provider. IVD has the potential of streamlining healthcare and offers an alternative when laboratory capacity is expensive or lacking altogether. Furthermore, it can increase the patient’s quality of life.
Karel van Eijkeren
more market segments.
cardiovascular
diagnostic imaging
For many disorders, high-quality images are essential for diagnostics and therapy. The...
home treatment & wearables
People will be managing their own health, with increased...
interventional systems
Medical interventions are increasingly minimally invasive. This reduces the chance of...
critical care systems
The care for a patient in critical condition is of vital importance....
radiation oncology
Radiation therapy is the most often used option for treating cancer. We...
regenerative medicine
Stem cell therapy and tissue technology hold major promise in the field...